Company news
iNtRON Biotechnology, Inc. news
Latest news releases, newest first.
iNtRON Bio, files Two Patent Applications for IMPA™ Platform-Based Gene Editing Technology
August 26, 2025
iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application
August 5, 2025
[iNtRON] Files U.S. Patent for Three Novel Endolysin-Based Drug Candidates Targeting Gram-Negative Bacteria
July 2, 2025
iNtRON Seeks a Strategic Partner to Explore the Promising Market for MRSA Decolonization
May 13, 2025